Charles Nicolette - CSO and Vice President R&D, Argos Therapeutics Inc
As of April 25, 2018
Charles Nicolette Net Worth
- Net worth is estimated to be at least $31.56K
- Owns at least 399,990 units of Argos Therapeutics Inc stock
- Sold an estimated value of $31.56K in the last 4 years at Argos Therapeutics Inc
Charles Nicolette Compensation at Argos Therapeutics Inc in 2016
- Earned a $325,000 salary and a $121 bonus
- Received a total compensation of $1,186,469
Charles Nicolette Trading
- Largest purchase of shares was 5,000 units , worth over $32.25K on August 27, 2015
- Largest sale of shares was 100,250 units , worth over $16.5K on January 12, 2018
- In total has made about 11 transactions over 4 years
- Usually trades in January, with the busiest year in 2018
Charles Nicolette
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Charles Nicolette Mailing Address
- Mailing address is Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 NC
Argos Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Jeffrey D. Abbey | 2016 | $450,000 | $356,500 | $1,029,892 | $26,477 | $1,862,869 |
| Jeffrey D. Abbey | 2015 | $450,000 | $202,500 | $714,502 | $14,861 | $1,381,863 |
| Charles A Nicolette, Ph.D. | 2016 | $325,000 | $121,875 | $720,925 | $18,669 | $1,186,469 |
| Charles A Nicolette, Ph.D. | 2015 | $325,000 | $108,875 | $446,564 | $17,217 | $897,656 |
| Lee F. Allen, M.D., Ph.D. | 2016 | $407,292 | $389,375 | $1,016,592 | $70,120 | $1,883,379 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm
Argos Therapeutics Inc Insider Trading
- The most recent transaction was 64,329 units sold on January 12, 2018 by Lori R Harrelson worth over $10.59K
- In the last 4 years, insiders at Argos Therapeutics Inc sold an estimated value of $79.34M and bought an estimated value of $13.75M
- The most active traders are Jeffrey Abbey, Chief Executive Officer, Pharmstandard Co Stock Joint, and Sa International Pharmstandard
- Insider trading is most common in January, with the busiest year in 2016
ARGOS THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||